150 results on '"Scher, Jose U."'
Search Results
2. Metabolic coordination between skin epithelium and type 17 immunity sustains chronic skin inflammation
3. Prevention of Psoriatic Arthritis: The Need for Prospective Studies
4. Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry
5. Responsiveness and Minimum Clinically Important Difference in Patient‐Reported Outcome Measures Among Patients With Psoriatic Arthritis: A Prospective Cohort Study
6. New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine
7. Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
8. National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
9. CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health
10. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation
11. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
12. Auto-deconvolution and molecular networking of gas chromatography–mass spectrometry data
13. Mitigation of Osteoclast‐Mediated Arthritic Bone Remodeling By Short Chain Fatty Acids.
14. Not your average joint: Towards precision medicine in psoriatic arthritis
15. KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease
16. Use of the Bath Ankylosing Spondylitis Disease Activity Index in Patients With Psoriatic Arthritis With and Without Axial Disease.
17. Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study
18. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings.
19. Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center.
20. Human microbiome, infections, and rheumatic disease
21. Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up
22. Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
23. Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis
24. Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin.
25. Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry
26. Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis.
27. Diet-Induced Arthritis in Pigs: Comment on the Article by Scher et al
28. Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis
29. Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases
30. Gut–Brain Axis Dysfunction May Be Associated With Psoriatic Arthritis: Comment on the Article by Scher et al
31. Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease
32. Role of Intestinal Dysbiosis and Nutrition in Rheumatoid Arthritis.
33. Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study.
34. Association of medication beliefs and self-efficacy with adherence in urban Hispanic and African–American rheumatoid arthritis patients
35. Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting.
36. Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis.
37. Nitric oxide synthases and osteoarthritis
38. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis
39. Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS–CoV‐2 Vaccination.
40. Does biologic therapy impact the development of PsA among patients with psoriasis?
41. The Anti-Inflammatory Effects of Prostaglandins
42. 15d-PGJ 2: The anti-inflammatory prostaglandin?
43. Moving the Goalpost Toward Remission: The Case for Combination Immunomodulatory Therapies in Psoriatic Arthritis.
44. Prevalence, Predictors, and Disease Activity of Sacroiliitis Among Patients with Crohn's Disease.
45. The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis.
46. A comparison of physical function instruments in psoriatic arthritis: HAQ-DI vs MDHAQ vs PROMIS10 global physical health.
47. Microbial-derived antigens and metabolites in spondyloarthritis.
48. Key opinion leaders - a critical perspective.
49. A Joint Effort: Improving the Identification of Spondyloarthritis in Patients With Inflammatory Bowel Disease.
50. COVID‐19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease‐Modifying Antirheumatic Drugs on Clinical Outcomes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.